EP3027261A2 - Kit d'injection d'un produit dans le cadre d'une intervention esthétique - Google Patents
Kit d'injection d'un produit dans le cadre d'une intervention esthétiqueInfo
- Publication number
- EP3027261A2 EP3027261A2 EP14790167.2A EP14790167A EP3027261A2 EP 3027261 A2 EP3027261 A2 EP 3027261A2 EP 14790167 A EP14790167 A EP 14790167A EP 3027261 A2 EP3027261 A2 EP 3027261A2
- Authority
- EP
- European Patent Office
- Prior art keywords
- injection
- cannula
- needle
- product
- treated
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
- A61M25/01—Introducing, guiding, advancing, emplacing or holding catheters
- A61M25/06—Body-piercing guide needles or the like
- A61M25/065—Guide needles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B2017/00743—Type of operation; Specification of treatment sites
- A61B2017/00792—Plastic surgery
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/178—Syringes
- A61M5/31—Details
- A61M5/32—Needles; Details of needles pertaining to their connection with syringe or hub; Accessories for bringing the needle into, or holding the needle on, the body; Devices for protection of needles
- A61M2005/3201—Coaxially assembled needle cannulas placed on top of another, e.g. needles having different diameters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
- A61M2025/0008—Catheters; Hollow probes having visible markings on its surface, i.e. visible to the naked eye, for any purpose, e.g. insertion depth markers, rotational markers or identification of type
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/178—Syringes
- A61M5/31—Details
- A61M5/32—Needles; Details of needles pertaining to their connection with syringe or hub; Accessories for bringing the needle into, or holding the needle on, the body; Devices for protection of needles
- A61M5/3287—Accessories for bringing the needle into the body; Automatic needle insertion
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/178—Syringes
- A61M5/31—Details
- A61M5/32—Needles; Details of needles pertaining to their connection with syringe or hub; Accessories for bringing the needle into, or holding the needle on, the body; Devices for protection of needles
- A61M5/329—Needles; Details of needles pertaining to their connection with syringe or hub; Accessories for bringing the needle into, or holding the needle on, the body; Devices for protection of needles characterised by features of the needle shaft
- A61M5/3291—Shafts with additional lateral openings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/46—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests having means for controlling depth of insertion
Definitions
- the invention relates to a method of injecting a product in the context of an aesthetic intervention, and an injection kit especially for the implementation of such a method.
- a filling product in particular based on hyaluronic acid
- a filling product under the skin of at least a part of the body of a patient, for example the face and / or neck of said patient , in order to temporarily remove the unsightly effects of aging of the skin, such as wrinkles and loosening of the skin, and / or to revitalize said skin by moisturizing the layers of the epidermis.
- autologous autologous pre-patient autologous injections such as platelet-rich plasma (PRP), for example for fibroblastic and collagenic stimulation of the skin to correct the unsightly effects due to aging, or fat, for example to correct the loss of volume of the skin due to trauma such as an accident or surgery.
- PRP platelet-rich plasma
- an injection cannula which has a rounded distal end and at least one lateral injection port disposed near said distal end.
- this type of cannula is particularly suitable for fillers, which are generally quite thick, and minimizes trauma to tissues and vessels deep layers of the skin, such as bruising, bruising or edema, as well as nervous trauma.
- the practitioner begins by piercing, with a needle having a sharp distal end, an area of the skin located not far from an area to be treated, to provide access to said area to be treated. Then, the practitioner removes the piercing needle and introduced through the hole thus formed an injection cannula as described above, then slides under the skin said cannula until the injection port opens into the area treat. It then injects the product into the area to be treated via the cannula, the product being for example contained in a syringe or in another type of container on which the said cannula is mounted.
- the practitioner may be forced to pinch the skin, sometimes several times, so as to cause bleeding through said hole, which can be painful for the patient and cause haematomas or swelling from the pinched area to bleeding.
- bleeding through said hole can be painful for the patient and cause haematomas or swelling from the pinched area to bleeding.
- the patient's recovery is lengthened, and the presence of unsightly traces can be harmful to the patient, who is then forced to temporary eviction during the convalescence.
- the invention aims to improve the prior art by proposing in particular an injection method allowing the practitioner to more easily and quickly perform the injection of a product, while significantly reducing the risk of trauma to the patient.
- the invention proposes a method of injecting a product in the context of an aesthetic intervention, said method providing the following successive steps of: piercing an area of the skin of a patient by means of a needle having a sharp distal end, said needle comprising a bore which extends between an upstream opening and a downstream opening opening into said distal end;
- an injection cannula which has at least one injection orifice
- the invention proposes a kit for injecting a product, particularly in the context of an aesthetic intervention, said kit comprising:
- At least one injection cannula which has at least one injection orifice
- At least one piercing needle of the skin of a patient which has a sharp distal end, and a bore extending between an upstream opening and a downstream opening which opens into said distal end, said bore being arranged to allow sliding the injection cannula beyond the distal end to at least one area to be treated under the skin.
- FIG. 1 represents an injection cannula according to one embodiment of the invention, FIG. 1a showing an enlarged view of zone A of FIG. 1;
- FIG. 2 shows two injection kits according to one embodiment of the invention, respectively;
- FIG. 3 represents an injection kit according to the invention, in which the injection cannula is introduced partially into the bore of the piercing needle;
- Figure 4 shows schematically in longitudinal section an injection cannula;
- FIG. 5 shows schematically in semi-longitudinal section a needle.
- injection kit especially for the implementation of such a method.
- the kit may also be used for the injection of a biocompatible product in the context of a medical or veterinary intervention, said product containing for example primarily anesthetic.
- the injection kit may be a single-use medical device for use by qualified personnel, including medical or paramedical personnel.
- the product to be injected may be a filling product, for example based on hyaluronic acid, to temporarily correct the unsightly effects of aging of the skin.
- a product based on hyaluronic acid fluid can be used to smooth the skin to reduce wrinkles.
- a product based on crosslinked hyaluronic acid therefore thicker, can be used to restore volume to the skin and / or to stretch said skin, in order to counterbalance a relaxation due to a loss of elasticity of said skin and / or to correct an asymmetry, in the case where an area of the skin has a loosening and / or loss of volume greater than its symmetrical zone.
- the product to be injected may also comprise an additive having anesthetic properties, for example based on lidocaine, in order to reduce the pain that the patient may feel during the injection, this pain being all the more important that the said product is thick.
- the product to be injected may also comprise an additive having antioxidant properties, for example base of mannitol, as well as vitamins to revitalize the layers of the skin in the area to be treated.
- the product to be injected may also be an autologous organic product previously taken from the patient, such as, for example, fat or platelet-rich plasma (PRP), for purely cosmetic purposes and / or to allow injections in auto-transplant, in particular to correct unsightly effects due to trauma such as an accident or surgery.
- an autologous organic product previously taken from the patient, such as, for example, fat or platelet-rich plasma (PRP), for purely cosmetic purposes and / or to allow injections in auto-transplant, in particular to correct unsightly effects due to trauma such as an accident or surgery.
- PRP platelet-rich plasma
- the area to be treated can be located on the face or neck of the patient, especially on the parts of the face or neck most prone to unsightly effects of aging of the skin, such as wrinkles or loosening.
- the area to be treated may be located at a commissure of the lips (subject to "folds of bitterness"), at an outer corner of an eye (subject to wrinkles in "crow's feet"), on a temple , on the forehead, and especially at the level of the glabella (subject to "lion's wrinkles”), at an orbital zone (where dark circles and / or pockets may appear), the valley of tears (located under one eye) of a cheekbone or cheek (where looseness and / or loss of skin volume can be seen).
- the area to be treated can also be located on other parts of the body particularly prone to such aging effects, as the hands, but also the arms, thighs, chest for women, especially at the neckline, the leather hairy, belly, or feet.
- the area to be treated may be located at various depths of the patient's skin.
- the area to be treated is generally located in a superficial layer of the skin, especially the epidermis or dermis.
- the area to be treated is rather located in a deep layer of the skin, especially the hypodermis.
- the area to be treated may be located in the stratum granulosum, that is to say the last layer of nucleated cells of the epidermis.
- the area to be treated may also be located under the epidermis, in particular between the dermis and the bone, and more particularly between the deep dermis and the periosteum of the bone.
- the practitioner can determine the zones to be treated by a careful examination of the patient, in particular by means of adapted lighting, to identify the possible lack of volume and the asymmetries which can result from it, but also for identify the blood vessels that should be avoided so as not to cause trauma to the patient.
- This examination includes local observations but also a global observation, especially with regard to the face, in order to correct the unsightly effects in a harmonious way and thus to guarantee a natural result for the patient.
- the practitioner can mark them with a hypoallergenic pencil.
- the practitioner must obviously take hygiene measures, especially before proceeding to the marking of the areas to be treated. To do this, the practitioner can clean the skin to remove any impurities, including makeup, and apply an antiseptic solution on said skin.
- the method provides a first step of piercing an area of the skin of the patient by means of a needle 1 having a sharp distal end 1a, to provide an access hole to the area to be treated.
- the injection kit comprises at least one such needle 1, said needle having a bore which extends between an upstream opening and a downstream opening which opens into the sharp distal end 1a.
- the needle 1 is made of stainless steel, for example SUS 304 alloy or AISI 304 alloy.
- the needle 1 comprises a base 2 on which its proximal end 1b, in which the upstream opening is formed, is mounted, the practitioner using said base to manipulate said needle.
- the proximal end 1b can be fixed by means of an adhesive in a housing provided for this purpose on the base.
- the needle 1 can be mounted retractable on the base 2, in particular to be retracted into said base after piercing the skin of the patient.
- the needle 1 also comprises a protection cap 8 intended to be mounted on the base 2 by covering said needle, in order to protect the practitioner from accidental punctures and possibly to ensure perfect sterility of said needle. needle before use.
- the base 2 and the cap 8 may be made of a polymer that is harmless to the human body, for example polypropylene or a copolymer based on polypropylene, such as ethylene-polypropylene.
- the base 2 and the cap 8 may be made of a non-flammable material, in particular without pyrogen.
- the method is implemented with a standard injection needle 1 provided with a plastic base 2 normally arranged to allow the mounting of said needle on the tip of a syringe, the drilling of the skin being made by grasping said base with two fingers.
- the needle 1 may be modified, for example by being cut longitudinally to form a gutter on which the bore extends between an upstream opening and a downstream opening which opens into the sharp distal end 1a.
- the needle 1 has a hemicylindrical geometry, the upstream opening being able to be arranged at the level of the proximal end 1b or along said needle.
- the base 2 may also be modified to facilitate manual gripping of the needle 1 during piercing of the skin, for example by providing that said base has two lateral gripping arms which extend from both sides. other of said needle.
- the area to be pierced may in particular be located on the patient's face, for example near an ear (retro-mandibular point), in a nasolabial area (at the level of the modiolus, naso-genital point), at the level of the zygomatic bone (zygomatic point), on a temple (temporal or frontal point) or above the glabella (glabellar point).
- the practitioner can reach several localized treatment areas on the face and / or the neck of the patient from the same hole in said area to be pierced, which limits the drilling of the skin, and thus the trauma for the patient.
- the number of zones to be pierced can be between one and five for each side of said face.
- the zone to be pierced may also be located on any other part of the patient's body, in particular on a hand, an arm or a thigh, on the chest, in particular at the level of the cleavage, on the scalp, on the stomach, or on a foot.
- the method provides for the use of an injection cannula 3 having at least one injection port 4.
- the cannula 3 has a rounded distal end 3a, which makes it possible not only to avoid the blood vessels and nerve trauma during the introduction of the cannula 3 under the skin of the patient, and thus to limit trauma for said patient, but also to limit the risk of accidental puncture for the practitioner.
- the injection kit comprises at least one such cannula 3, said cannula further having at least one injection port 4 disposed laterally near the distal end 3a.
- the orifice 4 has a diameter between 0.05 mm and 1 mm and is located about 2 mm from the rounded distal end 3a.
- the method provides a step following the piercing of the skin in which the needle 1 remains planted in the skin, the cannula 3 being introduced into the bore of said needle through its upstream opening.
- the method provides for a subsequent step of sliding the cannula 3 beyond the distal end 1a of the needle 1, until the orifice 4 opens into the zone treat.
- the bore of the needle 1 is arranged to allow the sliding of the cannula 3 beyond its distal end 1a to the area to be treated.
- the bore has a diameter greater than or equal to the outer diameter of the cannula 3, or substantially equal to said outer caliber.
- the upstream opening of the bore may be arranged to facilitate the insertion of the cannula 3 into the bore, and the base 2 of the needle 1 is wide enough to facilitate the introduction of the cannula 3 in the upstream opening and the bore.
- the practitioner can save time compared to conventional injection techniques because he does not have to locate the hole formed by the needle 1, since it remains positioned in said hole and that access to the zone to be treated is materialized by the upstream opening of the bore, which is easily localizable. Therefore, the practitioner does not need to resort to traumatic practices for the patient, such as pinching the skin of said patient several times to locate the hole by risking bleeding.
- the method then provides a step of injecting the product into the area to be treated via the cannula 3.
- the product is injected by means of a syringe or other type of container. on which the cannula 3 is mounted.
- the cannula 3 has a base 5 on which the proximal end 3b of said cannula is mounted, for example by being fixed by means of an adhesive in a housing provided for this purpose on said base, said base being intended to be mounted on a tip of a syringe containing the product to be injected.
- the base 5 can be of Luer-Lock® or Luer-Slip® type, to be mounted respectively by screwing or by friction on the tip of the syringe, these types being advantageously universal to allow the use of the cannula 3 with all types of syringes or other containers.
- the base 5 of the cannula 3 is arranged to fit into the base 2 of the needle 1 at the end of the sliding of said cannula into the bore, which ensures the practitioner stability of the positioning of the the cannula 3 before proceeding to the injection.
- the cannula 3 also comprises a protective cap 9 to be mounted on the base 5 surrounding said cannula, to ensure the protection and possibly perfect sterility of said cannula before use.
- the base 5 and the cap 9 may also be made of polypropylene or a polypropylene copolymer, especially ethylene-polypropylene.
- the base 5 and the cap 9 may be made of a non-flammable material, in particular without pyrogen.
- the dimensions of the cannula 3 may vary.
- the cannula 3 may have a reduced internal size if the product is fluid and on the contrary more important if the product is thick.
- the practitioner can inject a thick product without applying too much pressure to said product, which facilitates said injection and reduce pain for the patient.
- the molecules of the product are less subject to physical constraints and therefore less likely to be deteriorated.
- the cannula 3 may have an external gauge between 14G (14 gauges, which corresponds to a diameter of 2 mm) and 33G (0.2 mm), and especially between 22G (0.7 mm) and 25G ( 0.5 mm).
- the cannula 3 can also be flexible, to facilitate its guidance to the area to be treated, and then the positioning of its injection port 4 in said area to be treated.
- the flexibility of the cannula 3 is related to the outer caliber, said flexibility being all the more important that said outer caliber is reduced.
- the cannula 3 may be at least partially made of stainless steel, in particular alloy SUS 304 or alloy AISI 304 (crude chemical formula FeCnsNi-10), the latter being particularly remarkable for its good performance in terms of flexibility, robustness, elasticity and resistance to corrosion, and / or a shape memory alloy.
- the outer surface of the cannula 3 may have undergone a special treatment, for example based on silicone, in order to facilitate the sliding of said cannula under the skin of the patient, and thus to minimize the trauma for said patient, in particular the hematomas, bruises or edema.
- a special treatment for example based on silicone
- the base 5 of said cannula may include an identification marking of its outer caliber and / or its internal caliber.
- the identification marking consists of a coloration of the base 5, the coloration corresponding to the internal gauge and / or the external gauge of the cannula 3, as defined in particular by the NF EN ISO 6009 standard.
- the base 2 of the needle 1 has a coloration identical to that of the base 5 of the cannula 3, which identifies said needle and said base as belonging to the same injection kit.
- the needle 1 and the cannula 3 of the same kit may be packaged in the same transparent sterile bag, in particular based on polypropylene and / or polyethylene, said bag may also be flexible or rigid and / or include at least one portion based on peelable paper.
- the kit thus packaged can be stored in a box containing other kits also packaged in sachets to be protected from moisture and light during storage, the practitioner identifying at a glance the kit he has need by looking at the coloration of the bases 2, 5.
- the needle 1 and the cannula 3 of a kit are sterilized, for example by means of a process of sterilization by ethylene oxide (ETO), by ionizing radiation or by steam.
- the sachet may include indications for the practitioner, such as a lot number, the references of the conformity tests performed and / or the dimensions of the cannula 3 and / or the needle, and in particular information useful for safe use of the kit it contains, for example a date of sterilization and / or an expiry date, a notion restricting the use to qualified practitioners, a reference to the notified body and / or a marking of conformity to a standard, including the CE standard.
- the bag has a poor condition and / or an opening, the practitioner can know immediately that the kit contained in said bag must be destroyed for the safety of the patient.
- the cannula 3 may have a variable length, depending on the depth and / or the location of the zone to be treated with said cannula relative to the access hole. This length may especially be between 13 mm and 1 10 mm, and more particularly between 25 mm and 70 mm.
- the needle 1 has a greater or lesser length depending on the length of the associated cannula 3, to ensure a guide adapted to said length.
- the length of the needle 1 may in particular be between 4 mm and 30 mm.
- the cannula 3 may have graduations 6. arranged at regular intervals along its length, for example every centimeter.
- the base 5 of the cannula 3 may comprise on its periphery a marking 7 for locating the injection orifice 4 which is aligned with said injection orifice, which allows the practitioner to correctly orient said orifice. when it is positioned in the area to be treated.
- the marking of marking comprises a point 7 formed on the periphery of the base 5, said point being made in a sufficiently bright color to contrast with the color of said base.
- the marking may have another pattern, in particular in the form of an arrow. It can also be made in relief on the base 5, for example during the molding of said base, and optionally colored with a different shade of said base.
- the method may provide a step prior to piercing the skin, wherein an anesthetic is applied at least on and / or in the area to be pierced, thereby limiting both the pain due to said piercing and the pain due to the introduction of the cannula 3.
- the anesthetic product can be applied locally in the form of cream and / or patch, for example an Emla® type patch.
- the method may provide for successively treating several zones, and this by accessing from the same access hole, which is greatly facilitated by the maintenance of the needle 1 in said hole to guide the cannulas 3
- the practitioner has to change the cannula 3, in particular to change product or to use a cannula 3 of different length and / or internal gauge, leaving the needle 1 in place makes it easier to inserting new cannulas 3 through said access hole, and thus save time.
- the same kit may include several cannulas 3 which have for example the same external template, but different internal templates and / or lengths, to allow the practitioner to perform several injections with several products and / or in multiple areas to be treated with one kit.
- the same kit may also include several needles 1 which have for example different lengths.
- the practitioner can inject several products in the same area according to the aesthetic effects he wishes to bring to said area.
- the practitioner can inject several products of the same type which have different viscosities and / or the same product at different depths.
- the method can provide for moving a cannula 3 already introduced into the bore of the needle 1 to another area to be treated after injection of said product in a first zone.
- the practitioner may use a retractable mounted needle 1 on its base 2, said needle being retracted into said base after passage of the cannula 3 beyond the end 1a, that is to say after insertion of the cannula 3 under the skin by means of the needle 1.
- the injection can be performed only with the cannula 3 inserted into the skin, which allows the practitioner to more easily manipulate said cannula and perform an injection less traumatic for the patient.
- the needle 1 can be retracted before displacement of the cannula 3 to another area to be treated, in order to avoid injuring the patient in the area around the hole. access.
- the method may provide a radial displacement between the area that has just been treated and a new area to be treated to proceed to a new injection in said new area.
- the method may provide for repeating at least once such radial displacement from the treated area to another area to be treated and a subsequent step of injecting product into said other area.
- the practitioner can treat an entire area of the face, for example the forehead, a temple or a cheek, and this from a single access hole.
- a known technique In order to correct a loosening of the skin which is widely spread over an area of the face, for example on the forehead, on a temple or on a cheek, a known technique consists in injecting the product by bolus, that is to say, depositing several small doses of product on the whole of said zone by making several displacements in said zone, in order to stretch said skin over the whole area while giving it back volume.
- the practitioner can perform several bolus injections by performing several radial movements, including fan, in the same area.
- the practitioner can also use a particular technique called “topping" which is usually performed in a layer of the hypodermis, in order to achieve a smoothing surface and plump the skin deep.
- the practitioner makes sure to perform all the injections of topping in the same layer, and in particular at the same depth in said layer.
- the method may provide for moving the cannula 3 back during the bolus injection of the product, i.e., in a retrograde motion, to distribute the product over a substantial depth range and / or a wider area, which allows a more harmonious and therefore more natural result.
- the method may provide for moving the cannula 3 forward, in antegrade motion, during the bolus injection of the product.
- the practitioner easily removes the cannula 3 through guiding in the bore of the needle 1 and can perform a massage on the treated area, in order to evenly distribute the product and give a more homogeneous appearance and therefore more natural to the correction made. The patient can then see results that are immediately visible and lasting.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biophysics (AREA)
- Pulmonology (AREA)
- Engineering & Computer Science (AREA)
- Anesthesiology (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Hematology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Infusion, Injection, And Reservoir Apparatuses (AREA)
Abstract
Description
Claims
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR1357604A FR3009199A1 (fr) | 2013-07-31 | 2013-07-31 | Procede d'injection d'un produit dans le cadre d'une intervention esthetique |
PCT/FR2014/052000 WO2015015127A2 (fr) | 2013-07-31 | 2014-07-31 | Procédé d'injection d'un produit dans le cadre d'une intervention esthétique |
Publications (1)
Publication Number | Publication Date |
---|---|
EP3027261A2 true EP3027261A2 (fr) | 2016-06-08 |
Family
ID=49620090
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP14790167.2A Withdrawn EP3027261A2 (fr) | 2013-07-31 | 2014-07-31 | Kit d'injection d'un produit dans le cadre d'une intervention esthétique |
Country Status (3)
Country | Link |
---|---|
EP (1) | EP3027261A2 (fr) |
FR (1) | FR3009199A1 (fr) |
WO (1) | WO2015015127A2 (fr) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR3036289B1 (fr) * | 2015-05-19 | 2021-10-22 | Peter Cumbo | Dispositif d'injection de produit injectable comportant une canule coulissant dans une aiguille et systeme utilisant un tel dispositif |
US10569027B2 (en) * | 2016-04-20 | 2020-02-25 | Gayle MISLE | Epidural needle assembly |
WO2019178513A1 (fr) * | 2018-03-16 | 2019-09-19 | Siepser Steven B | Injecteur intra-vitréen transzonulaire |
US11464914B2 (en) * | 2019-10-21 | 2022-10-11 | Ripple Therapeutics Corporation | Intravitreal injector |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20090259126A1 (en) * | 2008-04-02 | 2009-10-15 | Laurimed, Llc | Methods and devices for delivering injections |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3840008A (en) * | 1972-04-18 | 1974-10-08 | Surgical Corp | Safety hypodermic needle |
US5098389A (en) * | 1990-06-28 | 1992-03-24 | Becton, Dickinson And Company | Hypodermic needle assembly |
GB2425484A (en) * | 2005-04-29 | 2006-11-01 | Univ Hospital Birmingham Nhs F | Improvement in and relating to catheter needles |
GB2471632B (en) * | 2008-05-02 | 2012-04-18 | Cook Biotech Inc | Self deploying SIS in needle |
DE102008025878A1 (de) * | 2008-05-29 | 2009-12-10 | Pajunk Gmbh & Co. Kg Besitzverwaltung | Kanüle, insbesondere für die Regionalanästhesie |
-
2013
- 2013-07-31 FR FR1357604A patent/FR3009199A1/fr not_active Withdrawn
-
2014
- 2014-07-31 EP EP14790167.2A patent/EP3027261A2/fr not_active Withdrawn
- 2014-07-31 WO PCT/FR2014/052000 patent/WO2015015127A2/fr active Application Filing
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20090259126A1 (en) * | 2008-04-02 | 2009-10-15 | Laurimed, Llc | Methods and devices for delivering injections |
Also Published As
Publication number | Publication date |
---|---|
WO2015015127A2 (fr) | 2015-02-05 |
WO2015015127A3 (fr) | 2015-04-09 |
FR3009199A1 (fr) | 2015-02-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US11890457B2 (en) | Aspiration and injection device | |
JP7035135B2 (ja) | 患者の皮膚の下へ鈍端カニューレを挿入するためのデバイス | |
WO2015015127A2 (fr) | Procédé d'injection d'un produit dans le cadre d'une intervention esthétique | |
US20120203137A1 (en) | Reduced-pain needle assembly | |
FR3009200A1 (fr) | Canule d'injection d'un produit biocompatible sous la peau d'un patient | |
Hertzog et al. | The flexible needle, a safe and easy new technique to inject the face | |
WO2017182728A1 (fr) | Dispositif de traitement esthétique comprenant un fil tenseur | |
KR20190137252A (ko) | 시린지 그립 | |
TWM645684U (zh) | 筋膜拉提器械組 | |
WO2011141940A1 (fr) | Canule pour injections | |
US11160934B2 (en) | Conical needle and methods of use and manufacturing | |
CN106580546A (zh) | 一种适合纹眉的眼球防护装置以及其使用方法 | |
de Cerqueira Leite et al. | Hyaluronic Acid for Dermic Hydration | |
JP2008212616A (ja) | 医療用無痛注射針 | |
JP2009125341A (ja) | 美容外科用注入容器体 | |
US20150141958A1 (en) | Devices and methods for vascular access | |
WO2005011800A1 (fr) | Systeme de canule intraveineuse | |
TWM367721U (en) | Needle seat | |
KR20160113789A (ko) | 피부 내 용액 주입을 위한 무 바늘 장치 | |
TWM486457U (zh) | 留置針插入用孔形成銷 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 20151214 |
|
AK | Designated contracting states |
Kind code of ref document: A2 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR |
|
AX | Request for extension of the european patent |
Extension state: BA ME |
|
DAX | Request for extension of the european patent (deleted) | ||
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: EXAMINATION IS IN PROGRESS |
|
17Q | First examination report despatched |
Effective date: 20200831 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: EXAMINATION IS IN PROGRESS |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: EXAMINATION IS IN PROGRESS |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
18D | Application deemed to be withdrawn |
Effective date: 20211105 |